Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events

被引:49
|
作者
Choi, Daein [1 ,2 ]
Choi, Seulggie [1 ]
Son, Joung Sik [3 ]
Oh, Sang Woo [4 ]
Park, Sang Min [1 ,3 ]
机构
[1] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea
[2] Pyeongchang Hlth Ctr & Cty Hosp, Pyeongchang, South Korea
[3] Seoul Natl Univ, Dept Family Med, Seoul, South Korea
[4] Dongguk Univ, Ilsan Hosp, Dept Family Med, Ctr Obes Metab & Nutr, Goyang, South Korea
来源
基金
新加坡国家研究基金会;
关键词
cardiovascular disease risk factors; cardiovascular events; obesity; BODY-MASS INDEX; CORONARY-HEART-DISEASE; SUBCUTANEOUS ADIPOSE-TISSUE; MECHANISMS LINKING OBESITY; CAUSE-SPECIFIC MORTALITY; WAIST CIRCUMFERENCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; VISCERAL FAT; RISK-FACTOR;
D O I
10.1161/JAHA.119.013471
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Body mass index and waist circumference (WC) are commonly used metrics that reflect general obesity and abdominal obesity. However, the impact of general and abdominal obesity discrepancies on the risk for major adverse cardiac events (MACE) is less explored. Methods and Results-The study population was derived from the Korean National Health Insurance Service-Health Screening Cohort. Among 315 982 participants aged 40 years or older who underwent health examinations between 2008 and 2009, body mass index and WC were used to determine the obesity status. The participants were followed from January 1, 2010 for MACE until December 31, 2015. Cox proportional hazards models were used to evaluate the association of obesity and the risk of MACE. Compared with men who were not obese, those with abdominal obesity without general obesity (adjusted hazard ratio (aHR) 1.29, 95% CI 1.16-1.43), and general and abdominal obesity (aHR 1.20, 95% CI 1.12-1.29) had elevated risk of MACE, while those with general obesity without abdominal obesity (aHR 1.06, 95% CI 0.98-1.16) did not. Similarly, women with abdominal obesity without general obesity (aHR 1.13, 95% CI 1.03-1.24) and those with general and abdominal obesity (aHR 1.15, 95% CI 1.06-1.25) had increased risk of MACE, while those with general obesity without abdominal obesity (aHR 1.07, 95% CI 0.88-1.30) did not. Conclusions-Abdominal obesity without general obesity was associated with an elevated risk of major cardiovascular outcomes while general obesity without abdominal obesity did not. Concurrent determination of body mass index and WC may be beneficial for the accurate determination of future cardiovascular risk.
引用
收藏
页码:1 / 8
页数:13
相关论文
共 50 条
  • [1] THE IMPACT OF PREOPERATIVE LENGTH OF STAY ON MAJOR ADVERSE RENAL AND CARDIAC EVENTS
    Tecson, Kristen M.
    Wheelan, Kevin R.
    McCullough, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 74 - 74
  • [2] Prevalence of Obesity in Transgender Adults and Its Impact on Major Adverse Cardiac and Cerebrovascular Events and Pulmonary Embolism: A PopulationBased Analysis
    Pingili, Adhvithi
    Sunkara, Praveena
    Vempati, Roopeessh
    Madhavaram, Hasmitha J.
    Vemula, Madhusha
    Lakkimsetti, Mohit
    Vasudev, Ishita
    Gummadi, Jyotsna
    Sagoo, Gurbina
    CIRCULATION, 2023, 148
  • [3] AN ODDITY IN OBESITY AND MAJOR ADVERSE CARDIAC EVENTS IN TRANSCATHETER AORTIC VALVE REPLACEMENT PATIENTS
    Tiu, David
    Bhayani, Siddharth
    Ambalavanan, Manoj
    Sreepathy, Pranati
    Twing, Aamir
    Zayyad, Zaid
    Dickens, Helena
    Meyer, Jonathan D.
    Slostad, Brody
    Kansal, Mayank
    Ibrahim, Khalil
    Shroff, Adhir Ramesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 867 - 867
  • [4] Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
    Huo, Bright
    Hirsch, Gregory M.
    Doucette, Steve
    Herman, Christine R.
    Gainer, Ryan
    Mokhtar, Ahmed T.
    CJC OPEN, 2022, 4 (01) : 12 - 19
  • [5] Preoperative β-Blocker Therapy and Stroke or Major Adverse Cardiac Events in Major Abdominal Surgery: A Retrospective Cohort Study
    McKenzie, Nicholas L.
    Ward, R. Parker
    Nagele, Peter
    Rubin, Daniel S.
    ANESTHESIOLOGY, 2023, 138 (01) : 42 - 54
  • [6] γ-Glutamyltransferase Subtype and Major Adverse Cardiac Events
    Ertem, Seyma
    Ertem, Ahmet Goktug
    Erdol, Mehmet Akif
    Demirtas, Koray
    Unal, Sefa
    Karanfil, Mustafa
    Akdi, Ahmet
    Yayla, Cagri
    ANGIOLOGY, 2020, 71 (03) : 292 - 292
  • [7] Getting to the HEART of Major Adverse Cardiac Events
    Samavedam, Srinivas
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2024, 28 (08) : 724 - 725
  • [8] Impact of medical checkup parameters on major adverse cardiovascular events in the general Japanese population
    Sugiura, Tomonori
    Takase, Hiroyuki
    Dohi, Yasuaki
    Yamashita, Sumiyo
    Seo, Yoshihiro
    PREVENTIVE MEDICINE REPORTS, 2024, 38
  • [9] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, So
    Ishii, Masanobu
    Otsuka, Yasuhiro
    Nakamura, Taishi
    Tsujita, Kenichi
    Matoba, Tetsuya
    Kohro, Takahide
    Oba, Yusuke
    Kabutoya, Tomoyuki
    Imai, Yasushi
    Kario, Kazuomi
    Kiyosue, Arihiro
    Mizuno, Yoshiko
    Nochioka, Kotaro
    Nakayama, Masaharu
    Iwai, Takamasa
    Miyamoto, Yoshihiro
    Sato, Hisahiko
    Akashi, Naoyuki
    Fujita, Hideo
    Nagai, Ryozo
    INTERNATIONAL JOURNAL OF CARDIOLOGY CARDIOVASCULAR RISK AND PREVENTION, 2023, 18
  • [10] Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
    Ikebe, S.
    Ishi, M.
    Otsuka, Y.
    Nakamura, T.
    Tsujita, K.
    Matoba, T.
    Kohro, T.
    Oba, Y.
    Kabutoya, T.
    Imai, Y.
    Kario, K.
    Kiyosue, A.
    Mizuno, Y.
    Nochioka, K.
    Nakayama, M.
    EUROPEAN HEART JOURNAL, 2023, 44